Drozd, A.; Kotlęga, D.; Nowacki, P.; Ciećwież, S.; Trochanowski, T.; Szczuko, M.
Fatty Acid Levels and Their Inflammatory Metabolites Are Associated with the Nondipping Status and Risk of Obstructive Sleep Apnea Syndrome in Stroke Patients. Biomedicines 2022, 10, 2200.
https://doi.org/10.3390/biomedicines10092200
AMA Style
Drozd A, Kotlęga D, Nowacki P, Ciećwież S, Trochanowski T, Szczuko M.
Fatty Acid Levels and Their Inflammatory Metabolites Are Associated with the Nondipping Status and Risk of Obstructive Sleep Apnea Syndrome in Stroke Patients. Biomedicines. 2022; 10(9):2200.
https://doi.org/10.3390/biomedicines10092200
Chicago/Turabian Style
Drozd, Arleta, Dariusz Kotlęga, Przemysław Nowacki, Sylwester Ciećwież, Tomasz Trochanowski, and Małgorzata Szczuko.
2022. "Fatty Acid Levels and Their Inflammatory Metabolites Are Associated with the Nondipping Status and Risk of Obstructive Sleep Apnea Syndrome in Stroke Patients" Biomedicines 10, no. 9: 2200.
https://doi.org/10.3390/biomedicines10092200
APA Style
Drozd, A., Kotlęga, D., Nowacki, P., Ciećwież, S., Trochanowski, T., & Szczuko, M.
(2022). Fatty Acid Levels and Their Inflammatory Metabolites Are Associated with the Nondipping Status and Risk of Obstructive Sleep Apnea Syndrome in Stroke Patients. Biomedicines, 10(9), 2200.
https://doi.org/10.3390/biomedicines10092200